Literature DB >> 16263238

The approximately 30-million-year-old ERVPb1 envelope gene is evolutionarily conserved among hominoids and Old World monkeys.

Lars Aagaard1, Palle Villesen, Anders Langfelt Kjeldbjerg, Finn Skou Pedersen.   

Abstract

Most human endogenous retroviruses (HERVs) are ancient and their genes are rendered nonfunctional by debilitating mutations. One exception is a recently discovered envelope gene located on chromosome 14. This envelope protein was also recently shown to be expressed in various human tissues and to mediate cell-cell fusion ex vivo. In this study, we demonstrate that this locus (designated ERVPb1) is preserved in Old World monkeys and that the reading frame is maintained. This is congruent with the entry of the HERV-P(b) group between 27 and 36 million years ago as suggested by long terminal repeat divergence. Although the coding capacity is generally lost in the HERV-IP supergroup, the analysis of nucleotide substitutions, lack of stop codons, and single-nucleotide polymorephisms strongly indicates a selective advantage of the ERVPb1 envelope genes during primate evolution. The purifying selection and tissue-specific expression of the human ERVPb1 envelope gene provide strong evidence of a beneficial role for the host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263238     DOI: 10.1016/j.ygeno.2005.08.011

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

Review 1.  HERVs in neuropathogenesis.

Authors:  Tove Christensen
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-27       Impact factor: 4.147

2.  The Oldest Co-opted gag Gene of a Human Endogenous Retrovirus Shows Placenta-Specific Expression and Is Upregulated in Diffuse Large B-Cell Lymphomas.

Authors:  Guney Boso; Katherine Fleck; Samuel Carley; Qingping Liu; Alicia Buckler-White; Christine A Kozak
Journal:  Mol Biol Evol       Date:  2021-12-09       Impact factor: 8.800

3.  Silencing of endogenous envelope genes in human choriocarcinoma cells shows that envPb1 is involved in heterotypic cell fusions.

Authors:  Lars Aagaard; Bolette Bjerregaard; Anders L Kjeldbjerg; Finn Skou Pedersen; Lars-Inge Larsson; John J Rossi
Journal:  J Gen Virol       Date:  2012-05-09       Impact factor: 3.891

4.  HERV-Derived Ervpb1 Is Conserved in Simiiformes, Exhibiting Expression in Hematopoietic Cell Lineages Including Macrophages.

Authors:  Ayumi Matsuzawa; Jiyoung Lee; So Nakagawa; Johbu Itoh; Mahoko Takahashi Ueda; Satomi Mitsuhashi; Yuta Kochi; Tomoko Kaneko-Ishino; Fumitoshi Ishino
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

5.  Improved integration time estimation of endogenous retroviruses with phylogenetic data.

Authors:  Hugo Martins; Palle Villesen
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

6.  Classification and characterization of human endogenous retroviruses; mosaic forms are common.

Authors:  Laura Vargiu; Patricia Rodriguez-Tomé; Göran O Sperber; Marta Cadeddu; Nicole Grandi; Vidar Blikstad; Enzo Tramontano; Jonas Blomberg
Journal:  Retrovirology       Date:  2016-01-22       Impact factor: 4.602

7.  Differential evolutionary fate of an ancestral primate endogenous retrovirus envelope gene, the EnvV syncytin, captured for a function in placentation.

Authors:  Cécile Esnault; Guillaume Cornelis; Odile Heidmann; Thierry Heidmann
Journal:  PLoS Genet       Date:  2013-03-28       Impact factor: 5.917

8.  Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution.

Authors:  Anders L Kjeldbjerg; Palle Villesen; Lars Aagaard; Finn Skou Pedersen
Journal:  BMC Evol Biol       Date:  2008-09-30       Impact factor: 3.260

9.  Structure of the Receptor Binding Domain of EnvP(b)1, an Endogenous Retroviral Envelope Protein Expressed in Human Tissues.

Authors:  Kevin R McCarthy; Joseph L Timpona; Simon Jenni; Louis-Marie Bloyet; Vesna Brusic; Welkin E Johnson; Sean P J Whelan; Lindsey R Robinson-McCarthy
Journal:  mBio       Date:  2020-11-17       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.